These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25317793)

  • 1. Effect of posterior subtenon injection of 40 mg of triamcinolone acetonide on glycemic control and serum cortisol and adrenocorticotropic hormone in diabetic patients.
    Kaderli B; Kivanc SA; Inan UU; Ersoy C; Yucel AA; Yilmaz S; Avci R
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2609-14. PubMed ID: 25317793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of posterior subtenon injection of 40 mg of triamcinolone acetonide on glycemic control and serum cortisol and adrenocorticotropic hormone in diabetic patients.
    Yolcu Ü; Ilhan A
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):1. PubMed ID: 25635966
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
    Choi YJ; Oh IK; Oh JR; Huh K
    Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
    Kim MW; Moon H; Yang SJ; Joe SG
    Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vessel diameter study: intravitreal vs posterior subtenon triamcinolone acetonide injection for diabetic macular edema.
    Kurt MM; Çekiç O; Akpolat Ç; Aslankurt M; Elçioğlu M
    Eye (Lond); 2017 Aug; 31(8):1155-1162. PubMed ID: 28338665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of subtenon triamcinolone acetonide injection for diabetic macular edema on retinal and choroidal circulation.
    Mawatari Y; Koga T; Inumaru J; Hirata A; Fukushima M; Tanihara H
    Am J Ophthalmol; 2005 Nov; 140(5):948-9. PubMed ID: 16310489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic complications of posterior subtenon injection of triamcinolone acetonide in type 2 diabetes patients.
    Toda J; Fukushima H; Kato S
    Diabetes Res Clin Pract; 2009 May; 84(2):e38-40. PubMed ID: 19233498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-adrenal axis function following intravitreal triamcinolone acetonide injection.
    Amiran MD; Yeung SN; Lang Y; Sartani G; Ishay A; Luboshitzky R
    Int Ophthalmol; 2013 Apr; 33(2):211-6. PubMed ID: 23132214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema.
    Choudhry S; Ghosh S
    Clin Exp Ophthalmol; 2007 Nov; 35(8):713-8. PubMed ID: 17997773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
    Yu SY; Nam DH; Lee DY
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):39-47. PubMed ID: 29030692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide.
    Chan LW; Hsu WC; Hsieh YT
    J Glaucoma; 2016 Mar; 25(3):e268-72. PubMed ID: 26950466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
    Bakri SJ; Kaiser PK
    Am J Ophthalmol; 2005 Feb; 139(2):290-4. PubMed ID: 15733990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema.
    Ozkurt YB; Akkaya S; Aksoy S; Evciman T; Haboğlu M
    J Ocul Pharmacol Ther; 2015 Oct; 31(8):455-60. PubMed ID: 26154736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema.
    Shimura M; Yasuda K; Minezaki T; Noma H
    Jpn J Ophthalmol; 2016 Sep; 60(5):401-7. PubMed ID: 27306783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of vitrectomized with nonvitrectomized eyes after subtenon injection of triamcinolone acetonide to treat diabetic macular edema: Retrospective comparative Analysis of an interventional case series.
    Pak KY; Choi BS; Park SW; Byon IS; Lee JE
    Indian J Ophthalmol; 2017 Jun; 65(6):488-492. PubMed ID: 28643714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suprachoroidal triamcinolone versus posterior subtenon triamcinolone either alone or formulated in the management of diabetic macular edema.
    Tharwat E; Ahmed REH; Eltantawy B; Ezzeldin ER; Elgazzar AF
    Int Ophthalmol; 2023 Dec; 43(12):4563-4571. PubMed ID: 37698662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
    Batioğlu F; Ozmert E; Parmak N; Celik S
    Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.